Compounds > n-(2-aminoethyl)-4-chlorobenzamide-hydrochloride

n-(2-aminoethyl)-4-chlorobenzamide-hydrochloride and Parkinson-Disease--Secondary

n-(2-aminoethyl)-4-chlorobenzamide-hydrochloride has been researched along with Parkinson-Disease--Secondary* in 1 studies

Other Studies

1 other study(ies) available for n-(2-aminoethyl)-4-chlorobenzamide-hydrochloride and Parkinson-Disease--Secondary

ArticleYear
Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzamides; Brain; Corpus Striatum; Dopamine; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease, Secondary; Pyridines; Rats; Selegiline; Substantia Nigra; Tyramine

1987